HEADER BLOOD CLOTTING 13-JUL-04 1U0N TITLE THE TERNARY VON WILLEBRAND FACTOR A1-GLYCOPROTEIN IBALPHA-BOTROCETIN TITLE 2 COMPLEX COMPND MOL_ID: 1; COMPND 2 MOLECULE: VON WILLEBRAND FACTOR; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: VWFA 1; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: BOTROCETIN; COMPND 8 CHAIN: B; COMPND 9 FRAGMENT: ALPHA CHAIN; COMPND 10 SYNONYM: PLATELET COAGGLUTININ; COMPND 11 MOL_ID: 3; COMPND 12 MOLECULE: BOTROCETIN; COMPND 13 CHAIN: C; COMPND 14 FRAGMENT: BETA CHAIN; COMPND 15 SYNONYM: PLATELET COAGGLUTININ; COMPND 16 MOL_ID: 4; COMPND 17 MOLECULE: PLATELET GLYCOPROTEIN IB; COMPND 18 CHAIN: D; COMPND 19 FRAGMENT: ALPHA CHAIN; COMPND 20 SYNONYM: GLYCOPROTEIN IBALPHA, GP-IB ALPHA, GPIBA, GPIB-ALPHA, CD42B- COMPND 21 ALPHA, CD42B; COMPND 22 ENGINEERED: YES; COMPND 23 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: VWF,F8VWF; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: BOTHROPS JARARACA; SOURCE 10 ORGANISM_COMMON: JARARACA; SOURCE 11 ORGANISM_TAXID: 8724; SOURCE 12 SECRETION: VENOM; SOURCE 13 MOL_ID: 3; SOURCE 14 ORGANISM_SCIENTIFIC: BOTHROPS JARARACA; SOURCE 15 ORGANISM_COMMON: JARARACA; SOURCE 16 ORGANISM_TAXID: 8724; SOURCE 17 SECRETION: VENOM; SOURCE 18 MOL_ID: 4; SOURCE 19 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 20 ORGANISM_COMMON: HUMAN; SOURCE 21 ORGANISM_TAXID: 9606; SOURCE 22 GENE: GP1BA; SOURCE 23 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 24 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 25 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 26 EXPRESSION_SYSTEM_CELL_LINE: SF9; SOURCE 27 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS; SOURCE 28 EXPRESSION_SYSTEM_PLASMID: PFASTBAC1 KEYWDS ROSSMANN FOLD, LRR MOTIF, C-TYPE LECTIN FOLD, PROTEIN-PROTEIN KEYWDS 2 COMPLEX, BLOOD CLOTTING EXPDTA X-RAY DIFFRACTION AUTHOR K.FUKUDA,R.C.LIDDINGTON REVDAT 3 27-OCT-21 1U0N 1 SEQADV REVDAT 2 24-FEB-09 1U0N 1 VERSN REVDAT 1 19-APR-05 1U0N 0 JRNL AUTH K.FUKUDA,T.DOGGETT,I.J.LAURENZI,R.C.LIDDINGTON,T.G.DIACOVO JRNL TITL THE SNAKE VENOM PROTEIN BOTROCETIN ACTS AS A BIOLOGICAL JRNL TITL 2 BRACE TO PROMOTE DYSFUNCTIONAL PLATELET AGGREGATION JRNL REF NAT.STRUCT.MOL.BIOL. V. 12 152 2005 JRNL REFN ISSN 1545-9993 JRNL PMID 15665869 JRNL DOI 10.1038/NSMB892 REMARK 2 REMARK 2 RESOLUTION. 2.95 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.0 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.95 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 6.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 171879.490 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 94.5 REMARK 3 NUMBER OF REFLECTIONS : 23643 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.213 REMARK 3 FREE R VALUE : 0.276 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1172 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.008 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.95 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 3.11 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 90.40 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 3505 REMARK 3 BIN R VALUE (WORKING SET) : 0.3600 REMARK 3 BIN FREE R VALUE : 0.3900 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.50 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 204 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.027 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5864 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 48.80 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 3.95000 REMARK 3 B22 (A**2) : 3.95000 REMARK 3 B33 (A**2) : -7.89000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.35 REMARK 3 ESD FROM SIGMAA (A) : 0.74 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.46 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.79 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.400 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 24.70 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.870 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.310 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.320 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.620 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.660 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.81 REMARK 3 BSOL : 119.4 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1U0N COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 26-JUL-04. REMARK 100 THE DEPOSITION ID IS D_1000023097. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 03-DEC-03 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : GRAPHITE REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 27144 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.950 REMARK 200 RESOLUTION RANGE LOW (A) : 200.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.500 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.6 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.09900 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 16.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.95 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.00 REMARK 200 COMPLETENESS FOR SHELL (%) : 87.9 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.34700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 68.44 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.90 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: SODIUM CITRATE, PH 7.5, VAPOR REMARK 280 DIFFUSION, SITTING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+1/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+3/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+1/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+3/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 110.98350 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 54.15750 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 54.15750 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 55.49175 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 54.15750 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 54.15750 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 166.47525 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 54.15750 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 54.15750 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 55.49175 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 54.15750 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 54.15750 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 166.47525 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 110.98350 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 THR A 705 CA C O CB OG1 CG2 REMARK 470 LYS B1035 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 CYS D 17 CA - CB - SG ANGL. DEV. = 6.7 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 500 -104.06 31.66 REMARK 500 GLU A 501 125.73 78.12 REMARK 500 SER A 510 69.92 -116.06 REMARK 500 SER A 523 2.25 -63.76 REMARK 500 GLU A 542 -31.18 -39.20 REMARK 500 ARG A 543 31.10 -99.02 REMARK 500 TRP A 550 -108.87 -149.80 REMARK 500 HIS A 559 -103.61 -133.53 REMARK 500 GLN A 604 -67.96 -102.94 REMARK 500 ARG A 611 56.66 -118.27 REMARK 500 PRO A 670 -72.05 -50.94 REMARK 500 ASN A 672 74.67 -66.32 REMARK 500 GLU A 682 -7.51 -55.87 REMARK 500 PRO A 703 -78.01 -72.91 REMARK 500 SER B1004 118.65 -35.29 REMARK 500 LYS B1043 98.31 -67.11 REMARK 500 ILE B1044 -48.40 -23.54 REMARK 500 VAL B1056 -80.86 -83.85 REMARK 500 THR B1057 -46.94 -21.00 REMARK 500 LYS B1058 36.20 -87.67 REMARK 500 ASN B1059 -41.92 -168.78 REMARK 500 GLN B1061 97.15 10.41 REMARK 500 SER B1062 -156.15 -173.02 REMARK 500 GLU B1077 171.07 -59.24 REMARK 500 CYS B1080 43.47 -102.22 REMARK 500 SER B1085 0.46 -66.18 REMARK 500 SER B1091 -66.47 -124.76 REMARK 500 ASN B1094 49.00 -141.74 REMARK 500 GLU B1097 -64.70 -20.63 REMARK 500 THR B1099 -16.16 -161.35 REMARK 500 LEU B1110 -11.32 74.74 REMARK 500 PRO C2003 151.95 -46.01 REMARK 500 PRO C2004 163.22 -45.31 REMARK 500 ASP C2005 -20.48 70.83 REMARK 500 TRP C2006 -139.99 -90.08 REMARK 500 SER C2007 -169.04 -168.01 REMARK 500 GLU C2010 29.01 43.08 REMARK 500 GLN C2034 113.91 -174.12 REMARK 500 THR C2035 117.95 -37.40 REMARK 500 HIS C2038 -158.92 -143.95 REMARK 500 PHE C2042 102.86 -51.27 REMARK 500 LEU C2054 -9.20 -59.64 REMARK 500 THR C2055 -102.66 -69.81 REMARK 500 SER C2056 92.42 27.10 REMARK 500 GLU C2057 -7.56 163.95 REMARK 500 THR C2080 -15.01 -49.04 REMARK 500 TYR C2087 -19.82 -40.71 REMARK 500 LEU C2092 39.09 35.08 REMARK 500 THR C2104 -44.98 -29.83 REMARK 500 ASN C2105 16.89 -143.48 REMARK 500 REMARK 500 THIS ENTRY HAS 80 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1AUQ RELATED DB: PDB REMARK 900 THE UNCOMPLEXED A1 (WILD TYPE) REMARK 900 RELATED ID: 1IJB RELATED DB: PDB REMARK 900 THE MUTANT A1 (I546V) REMARK 900 RELATED ID: 1IJK RELATED DB: PDB REMARK 900 THE MUTANT A1:BOTROCETIN COMPLEX DBREF 1U0N A 498 705 UNP P04275 VWF_HUMAN 1261 1468 DBREF 1U0N B 1001 1133 UNP P22029 BOTA_BOTJA 1 133 DBREF 1U0N C 2001 2125 UNP P22030 BOTB_BOTJA 1 125 DBREF 1U0N D 1 265 UNP P07359 GP1BA_HUMAN 17 281 SEQADV 1U0N GLN D 21 UNP P07359 ASN 37 ENGINEERED MUTATION SEQADV 1U0N GLN D 159 UNP P07359 ASN 175 ENGINEERED MUTATION SEQRES 1 A 208 ASP ILE SER GLU PRO PRO LEU HIS ASP PHE TYR CYS SER SEQRES 2 A 208 ARG LEU LEU ASP LEU VAL PHE LEU LEU ASP GLY SER SER SEQRES 3 A 208 ARG LEU SER GLU ALA GLU PHE GLU VAL LEU LYS ALA PHE SEQRES 4 A 208 VAL VAL ASP MET MET GLU ARG LEU ARG ILE SER GLN LYS SEQRES 5 A 208 TRP VAL ARG VAL ALA VAL VAL GLU TYR HIS ASP GLY SER SEQRES 6 A 208 HIS ALA TYR ILE GLY LEU LYS ASP ARG LYS ARG PRO SER SEQRES 7 A 208 GLU LEU ARG ARG ILE ALA SER GLN VAL LYS TYR ALA GLY SEQRES 8 A 208 SER GLN VAL ALA SER THR SER GLU VAL LEU LYS TYR THR SEQRES 9 A 208 LEU PHE GLN ILE PHE SER LYS ILE ASP ARG PRO GLU ALA SEQRES 10 A 208 SER ARG ILE ALA LEU LEU LEU MET ALA SER GLN GLU PRO SEQRES 11 A 208 GLN ARG MET SER ARG ASN PHE VAL ARG TYR VAL GLN GLY SEQRES 12 A 208 LEU LYS LYS LYS LYS VAL ILE VAL ILE PRO VAL GLY ILE SEQRES 13 A 208 GLY PRO HIS ALA ASN LEU LYS GLN ILE ARG LEU ILE GLU SEQRES 14 A 208 LYS GLN ALA PRO GLU ASN LYS ALA PHE VAL LEU SER SER SEQRES 15 A 208 VAL ASP GLU LEU GLU GLN GLN ARG ASP GLU ILE VAL SER SEQRES 16 A 208 TYR LEU CYS ASP LEU ALA PRO GLU ALA PRO PRO PRO THR SEQRES 1 B 133 ASP CYS PRO SER GLY TRP SER SER TYR GLU GLY ASN CYS SEQRES 2 B 133 TYR LYS PHE PHE GLN GLN LYS MET ASN TRP ALA ASP ALA SEQRES 3 B 133 GLU ARG PHE CYS SER GLU GLN ALA LYS GLY GLY HIS LEU SEQRES 4 B 133 VAL SER ILE LYS ILE TYR SER LYS GLU LYS ASP PHE VAL SEQRES 5 B 133 GLY ASP LEU VAL THR LYS ASN ILE GLN SER SER ASP LEU SEQRES 6 B 133 TYR ALA TRP ILE GLY LEU ARG VAL GLU ASN LYS GLU LYS SEQRES 7 B 133 GLN CYS SER SER GLU TRP SER ASP GLY SER SER VAL SER SEQRES 8 B 133 TYR GLU ASN VAL VAL GLU ARG THR VAL LYS LYS CYS PHE SEQRES 9 B 133 ALA LEU GLU LYS ASP LEU GLY PHE VAL LEU TRP ILE ASN SEQRES 10 B 133 LEU TYR CYS ALA GLN LYS ASN PRO PHE VAL CYS LYS SER SEQRES 11 B 133 PRO PRO PRO SEQRES 1 C 125 ASP CYS PRO PRO ASP TRP SER SER TYR GLU GLY HIS CYS SEQRES 2 C 125 TYR ARG PHE PHE LYS GLU TRP MET HIS TRP ASP ASP ALA SEQRES 3 C 125 GLU GLU PHE CYS THR GLU GLN GLN THR GLY ALA HIS LEU SEQRES 4 C 125 VAL SER PHE GLN SER LYS GLU GLU ALA ASP PHE VAL ARG SEQRES 5 C 125 SER LEU THR SER GLU MET LEU LYS GLY ASP VAL VAL TRP SEQRES 6 C 125 ILE GLY LEU SER ASP VAL TRP ASN LYS CYS ARG PHE GLU SEQRES 7 C 125 TRP THR ASP GLY MET GLU PHE ASP TYR ASP ASP TYR TYR SEQRES 8 C 125 LEU ILE ALA GLU TYR GLU CYS VAL ALA SER LYS PRO THR SEQRES 9 C 125 ASN ASN LYS TRP TRP ILE ILE PRO CYS THR ARG PHE LYS SEQRES 10 C 125 ASN PHE VAL CYS GLU PHE GLN ALA SEQRES 1 D 265 HIS PRO ILE CYS GLU VAL SER LYS VAL ALA SER HIS LEU SEQRES 2 D 265 GLU VAL ASN CYS ASP LYS ARG GLN LEU THR ALA LEU PRO SEQRES 3 D 265 PRO ASP LEU PRO LYS ASP THR THR ILE LEU HIS LEU SER SEQRES 4 D 265 GLU ASN LEU LEU TYR THR PHE SER LEU ALA THR LEU MET SEQRES 5 D 265 PRO TYR THR ARG LEU THR GLN LEU ASN LEU ASP ARG CYS SEQRES 6 D 265 GLU LEU THR LYS LEU GLN VAL ASP GLY THR LEU PRO VAL SEQRES 7 D 265 LEU GLY THR LEU ASP LEU SER HIS ASN GLN LEU GLN SER SEQRES 8 D 265 LEU PRO LEU LEU GLY GLN THR LEU PRO ALA LEU THR VAL SEQRES 9 D 265 LEU ASP VAL SER PHE ASN ARG LEU THR SER LEU PRO LEU SEQRES 10 D 265 GLY ALA LEU ARG GLY LEU GLY GLU LEU GLN GLU LEU TYR SEQRES 11 D 265 LEU LYS GLY ASN GLU LEU LYS THR LEU PRO PRO GLY LEU SEQRES 12 D 265 LEU THR PRO THR PRO LYS LEU GLU LYS LEU SER LEU ALA SEQRES 13 D 265 ASN ASN GLN LEU THR GLU LEU PRO ALA GLY LEU LEU ASN SEQRES 14 D 265 GLY LEU GLU ASN LEU ASP THR LEU LEU LEU GLN GLU ASN SEQRES 15 D 265 SER LEU TYR THR ILE PRO LYS GLY PHE PHE GLY SER HIS SEQRES 16 D 265 LEU LEU PRO PHE ALA PHE LEU HIS GLY ASN PRO TRP LEU SEQRES 17 D 265 CYS ASN CYS GLU ILE LEU TYR PHE ARG ARG TRP LEU GLN SEQRES 18 D 265 ASP ASN ALA GLU ASN VAL TYR VAL TRP LYS GLN GLY VAL SEQRES 19 D 265 ASP VAL LYS ALA MET THR SER ASN VAL ALA SER VAL GLN SEQRES 20 D 265 CYS ASP ASN SER ASP LYS PHE PRO VAL TYR LYS TYR PRO SEQRES 21 D 265 GLY LYS GLY CYS PRO HELIX 1 1 SER A 526 ARG A 543 1 18 HELIX 2 2 ARG A 573 GLN A 583 1 11 HELIX 3 3 SER A 593 GLN A 604 1 12 HELIX 4 4 MET A 630 ARG A 632 5 3 HELIX 5 5 ASN A 633 LYS A 644 1 12 HELIX 6 6 ASN A 658 ALA A 669 1 12 HELIX 7 7 ASP A 681 ASP A 696 1 16 HELIX 8 8 ASN B 1022 ALA B 1034 1 13 HELIX 9 9 SER B 1046 LYS B 1058 1 13 HELIX 10 10 HIS C 2022 GLN C 2034 1 13 HELIX 11 11 SER C 2044 THR C 2055 1 12 HELIX 12 12 PRO C 2103 ASN C 2106 5 4 HELIX 13 13 ALA D 49 MET D 52 5 4 HELIX 14 14 LEU D 214 ASN D 223 1 10 HELIX 15 15 VAL D 243 VAL D 246 5 4 HELIX 16 16 PRO D 255 TYR D 259 5 5 SHEET 1 A 5 VAL A 551 ARG A 552 0 SHEET 2 A 5 LEU A 513 ASP A 520 1 N LEU A 513 O ARG A 552 SHEET 3 A 5 SER A 615 MET A 622 1 O ILE A 617 N VAL A 516 SHEET 4 A 5 VAL A 646 ILE A 653 1 O ILE A 653 N MET A 622 SHEET 5 A 5 PHE A 675 LEU A 677 1 O LEU A 677 N GLY A 652 SHEET 1 B 6 VAL A 551 ARG A 552 0 SHEET 2 B 6 LEU A 513 ASP A 520 1 N LEU A 513 O ARG A 552 SHEET 3 B 6 VAL A 555 TYR A 558 1 O VAL A 556 N LEU A 519 SHEET 4 B 6 SER A 562 ILE A 566 -1 O HIS A 563 N GLU A 557 SHEET 5 B 6 LYS D 237 SER D 241 -1 O LYS D 237 N ALA A 564 SHEET 6 B 6 TYR D 228 LYS D 231 -1 N LYS D 231 O ALA D 238 SHEET 1 C 4 SER B1007 SER B1008 0 SHEET 2 C 4 CYS B1013 MET B1021 -1 O TYR B1014 N SER B1007 SHEET 3 C 4 ASN B1124 SER B1130 -1 O SER B1130 N CYS B1013 SHEET 4 C 4 HIS B1038 LEU B1039 -1 N HIS B1038 O LYS B1129 SHEET 1 D 4 TRP B1115 LEU B1118 0 SHEET 2 D 4 CYS B1103 GLU B1107 -1 N CYS B1103 O LEU B1118 SHEET 3 D 4 TYR B1066 VAL B1073 -1 N ALA B1067 O LEU B1106 SHEET 4 D 4 PHE C2077 TRP C2079 -1 O GLU C2078 N ARG B1072 SHEET 1 E 3 ARG C2015 MET C2021 0 SHEET 2 E 3 LYS C2117 PHE C2123 -1 O CYS C2121 N ARG C2015 SHEET 3 E 3 ALA C2037 LEU C2039 -1 N HIS C2038 O GLU C2122 SHEET 1 F 5 ARG C2015 MET C2021 0 SHEET 2 F 5 LYS C2117 PHE C2123 -1 O CYS C2121 N ARG C2015 SHEET 3 F 5 VAL C2064 TRP C2065 1 N TRP C2065 O ASN C2118 SHEET 4 F 5 GLU C2097 SER C2101 -1 O SER C2101 N VAL C2064 SHEET 5 F 5 TRP C2108 PRO C2112 -1 O ILE C2111 N CYS C2098 SHEET 1 G10 GLU D 5 VAL D 9 0 SHEET 2 G10 HIS D 12 ASN D 16 -1 O ASN D 16 N GLU D 5 SHEET 3 G10 ILE D 35 HIS D 37 1 O HIS D 37 N VAL D 15 SHEET 4 G10 GLN D 59 ASN D 61 1 O ASN D 61 N LEU D 36 SHEET 5 G10 THR D 81 ASP D 83 1 O THR D 81 N LEU D 60 SHEET 6 G10 VAL D 104 ASP D 106 1 O ASP D 106 N LEU D 82 SHEET 7 G10 GLU D 128 TYR D 130 1 O GLU D 128 N LEU D 105 SHEET 8 G10 LYS D 152 SER D 154 1 O LYS D 152 N LEU D 129 SHEET 9 G10 THR D 176 LEU D 178 1 O LEU D 178 N LEU D 153 SHEET 10 G10 PHE D 199 PHE D 201 1 O PHE D 201 N LEU D 177 SHEET 1 H 2 THR D 45 SER D 47 0 SHEET 2 H 2 LYS D 69 GLN D 71 1 O GLN D 71 N PHE D 46 SSBOND 1 CYS A 509 CYS A 695 1555 1555 2.04 SSBOND 2 CYS B 1002 CYS B 1013 1555 1555 2.04 SSBOND 3 CYS B 1030 CYS B 1128 1555 1555 2.03 SSBOND 4 CYS B 1080 CYS C 2075 1555 1555 2.03 SSBOND 5 CYS B 1103 CYS B 1120 1555 1555 2.04 SSBOND 6 CYS C 2002 CYS C 2013 1555 1555 2.03 SSBOND 7 CYS C 2030 CYS C 2121 1555 1555 2.03 SSBOND 8 CYS C 2098 CYS C 2113 1555 1555 2.04 SSBOND 9 CYS D 4 CYS D 17 1555 1555 2.03 SSBOND 10 CYS D 209 CYS D 248 1555 1555 2.03 SSBOND 11 CYS D 211 CYS D 264 1555 1555 2.04 CISPEP 1 PRO A 703 PRO A 704 0 0.16 CRYST1 108.315 108.315 221.967 90.00 90.00 90.00 P 41 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009232 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009232 0.000000 0.00000 SCALE3 0.000000 0.000000 0.004505 0.00000